 | For Adults |
ImmuneBioflora® is an exclusive combination of K-12® and LGG® based upon a stability and clinically tested formula – a combination of the best documented probiotic strains colonizing and protecting the gut (L. rhamnosus, LGG®) and the oral-pharyngeal mucosa (S. salivarius K-12®).
K-12® allows the formation of a protective microflora in the oral-pharyngeal cavity after the antibiotic course. LGG® reduces antibiotic-associated side effects including gas, bloating, and diarrhea and modifies intestinal microbiota, alleviating antibiotic-associated changes.
K-12® reduces throat symptoms in subjects (2 to 18 years) with acute respiratory infection receiving antibiotics. Exposure to antibiotics significantly reduces the abundance of S. salivarius in the oral-pharyngeal cavity and induce selection of resistant strains in the oral microflora.
K-12® effectively colonizes the oral cavity and the oro- and nasopharynx and protects from respiratory infections. Global Guidelines recommend the use of LGG® strain for antibiotic-associated diarrhea, because it effectively colonizes the gut and reduces the incidence of AAD.
Simply one lozenge per day after tooth brushing, let it dissolve slowly in the mouth.
ImmuneBioflora® is a registered trademark of Bluestone Pharma GmbH.
LGG® is a trademark of Chr. Hansen A/S.
K-12® is a licensed trademark by Bluestone Pharma GmbH.